Sebastián Bernales Odino

Sebastián Bernales holds a degree in Biochemistry from Universidad Católica de Chile, earned his doctorate and served as a postdoctoral fellow at the University of California in San Francisco (UCSF). His first contributions to science were in the area of cellular biology, specifically the process of learning how cells react to the accumulation of unfolded proteins and controlling organelles’ homeostasis. Co-founder and advisor of various biotech companies and a member of board of directors at Fundación Ciencia & Vida and Fundación EcoScience. Prior to that he was Vice President of Medivation Inc (which was acquired by Pfizer in 2006) that developed XTANDI (enzalutamide), an approved inhibitor of the androgen receptor used to treat prostate cancer. Currently, Bernales lives in Silicon Valley, California, where he researches treatments for different diseases.